These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. Prospective studies on the progress of sicca symptoms in Sjögren's syndrome: subclinical disease develops into the clinical syndrome. Ichikawa Y; Takaya M; Uchiyama M; Shimizu H; Tokunaga M; Saitoh H; Arimori S Tokai J Exp Clin Med; 1988 Jun; 13(2):85-90. PubMed ID: 3250005 [TBL] [Abstract][Full Text] [Related]
34. Keratoconjunctivitis sicca and new techniques in its management. Flynn F Med J Aust; 1967 Jan; 1(2):33-41. PubMed ID: 6016902 [No Abstract] [Full Text] [Related]
35. Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren's syndrome. Yokoi N; Sonomura Y; Kato H; Komuro A; Kinoshita S Eye (Lond); 2015 Sep; 29(9):1204-12. PubMed ID: 26160526 [TBL] [Abstract][Full Text] [Related]
37. Influence of bromhexine on tear lysozome level in keratoconjunctivitis sicca. Scharf JM; Obedeanu N; Meshulam T; Nahir M; Merzbach D; Scharf JA; Zonis S Am J Ophthalmol; 1981 Jul; 92(1):21-3. PubMed ID: 7258276 [No Abstract] [Full Text] [Related]
38. Sjögren's syndrome presenting as recalcitrant generalized pruritus. Some remarks about its relation to collagen diseases and the connection of rheumatoid arthritis with the Sicca syndrome. Feuerman EJ Dermatologica; 1968; 137(2):74-86. PubMed ID: 5668251 [No Abstract] [Full Text] [Related]
39. Keratoconjunctitis sicca versus dry mouth and autoantibodies in primary and secondary Sjögren's syndrome. Kitagawa K; Nakamura T; Sugai S Adv Exp Med Biol; 2002; 506(Pt B):1195-9. PubMed ID: 12614051 [No Abstract] [Full Text] [Related]
40. [Sjogren's syndrome]. Rasković S; Bogić M; Perić-Popadić A; Tomić-Spirić V Srp Arh Celok Lek; 1997; 125(1-2):54-8. PubMed ID: 17974357 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]